Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Parenteral Injection of an Extended Release Kappa-receptor Opioid Sebacoyl Dinalbuphine Ester for Pain Management After Cesarean Section: a Randomized, Open-label, Non-inferiority Trial

NCT06344169 is registered in ClinicalTrials.gov with Dalin Tzu Chi General Hospital as lead sponsor.

NCT NCT06344169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06344169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Parenteral Injection of an Extended Release Kappa-receptor Opioid Sebacoyl Dinalbuphine Ester for Pain Management After Cesarean Section: a Randomized, Open-label, Non-inferiority Trial
Lead sponsor
Dalin Tzu Chi General Hospital
Phase
Phase 2/3
Overall status
Recruiting
Start date
May 6, 2024
Completion date
June 14, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cesarean section, chronic post-surgical pain, postsurgical pain